Contact
searchSearch
HMP Global

Cardiovascular

Featured Article

Headshot and logo for Talking Therapeutics with Douglas Jennings, PharmD
Talking Therapeutics
Cutting Through Cost Barriers for Heart Failure Medications
03/02/2023
Douglas L. Jennings, PharmD, FACC, FAHA, FCCP, FHFSA, BCPS
In the latest installment of Talking Therapeutics, Dr Jennings provides a brief history of heart failure medications and discusses the cost effectiveness of quadruple, triple, and double therapy regimens.
In the latest installment of Talking Therapeutics, Dr Jennings provides a brief history of heart failure medications and discusses the cost effectiveness of quadruple, triple, and double therapy regimens.
In the latest installment of...
03/02/2023
Pharmacy Learning Network
From Pharmacy Learning Network
Headshot and logo for Talking Therapeutics with Douglas Jennings, PharmD
Talking Therapeutics
ACC Updates Part 2
06/01/2021
Douglas L. Jennings, PharmD, FACC, FAHA, FCCP, FHFSA, BCPS
Last week’s edition of Talking Therapeutics highlighted several new and exciting studies related to heart failure drug therapies. This week we tackle three more pivotal trials from this year’s exciting conference.
Last week’s edition of Talking Therapeutics highlighted several new and exciting studies related to heart failure drug therapies. This week we tackle three more pivotal trials from this year’s exciting conference.
Last week’s edition of Talking...
06/01/2021
Pharmacy Learning Network
From Pharmacy Learning Network
Headshot of Mark Munger, PharmD
Commentary
An Update on Heart Failure: World-Wide Burden, Rural Versus Urban Adults, Ethnic Disparities, and Remote Monitoring
06/01/2021
Mark A. Munger, PharmD, FCCP, FACC, FHFSA
Mark Munger, PharmD, provides up-to-date information on heart failure across the world, related mortality in rural versus urban adults, ethnic disparities in US outcomes, and potential innovations of heart failure care.
Mark Munger, PharmD, provides up-to-date information on heart failure across the world, related mortality in rural versus urban adults, ethnic disparities in US outcomes, and potential innovations of heart failure care.
Mark Munger, PharmD, provides...
06/01/2021
Pharmacy Learning Network
From Pharmacy Learning Network
News
Multidisciplinary Intervention Has No Significant Effect on Heart Failure Readmissions
05/21/2021
A multidisciplinary educational approach to reduce 30-day heart failure readmissions failed to have a significant impact—although readmission rates for patients in both the intervention group and the control group were below national norms.
A multidisciplinary educational approach to reduce 30-day heart failure readmissions failed to have a significant impact—although readmission rates for patients in both the intervention group and the control group were below national norms.
A multidisciplinary educational...
05/21/2021
Pharmacy Learning Network
From Pharmacy Learning Network
Talking Therapeutics
Heart Failure Treatment Insight From ACC.2021
05/19/2021
Douglas L. Jennings, PharmD, FACC, FAHA, FCCP, FHFSA, BCPS
In this week's installment of Talking Therapeutics, Dr Jennings offers a breakdown on the latest heart failure therapy data, which was recently presented at the American College of Cardiology's annual meeting.
In this week's installment of Talking Therapeutics, Dr Jennings offers a breakdown on the latest heart failure therapy data, which was recently presented at the American College of Cardiology's annual meeting.
In this week's installment of...
05/19/2021
Pharmacy Learning Network
From Pharmacy Learning Network
Commentary
Hypertension, Hyperlipidemia for Developing and Sustaining Atrial Fibrillation
05/04/2021
“Goal-directed use of antihypertensives and statin drugs appear to be effective strategies to reduce atrial fibrillation incidence, morbidity, and mortality,” says Mark Munger, PharmD.
“Goal-directed use of antihypertensives and statin drugs appear to be effective strategies to reduce atrial fibrillation incidence, morbidity, and mortality,” says Mark Munger, PharmD.
“Goal-directed use of...
05/04/2021
Pharmacy Learning Network
From Pharmacy Learning Network
Talking Therapeutics
V is for Victory in Heart Failure
04/28/2021
In this week’s issue of Talking Therapeutics, Dr Jennings explores the science and promise of a recently approved novel medication for patients with HFrEF.
In this week’s issue of Talking Therapeutics, Dr Jennings explores the science and promise of a recently approved novel medication for patients with HFrEF.
In this week’s issue of Talking...
04/28/2021
Pharmacy Learning Network
From Pharmacy Learning Network
Talking Therapeutics
Targeting Inflammation to Treat Coronary Artery Disease
04/20/2021
Dr Jennings reviews evidence supporting colchicine use to further reduce residual disease burden in coronary artery disease but highlights why pharmacists need to keep several things in mind when dispensing colchicine to ensure that patients...
Dr Jennings reviews evidence supporting colchicine use to further reduce residual disease burden in coronary artery disease but highlights why pharmacists need to keep several things in mind when dispensing colchicine to ensure that patients...
Dr Jennings reviews evidence...
04/20/2021
Pharmacy Learning Network
From Pharmacy Learning Network
Commentary
How Do We Achieve Optimal Population Cardiovascular Health?
02/10/2021
Mark Munger, PharmD, professor, Pharmacotherapy and Internal Medicine, University of Utah, discusses the declining rate of cardiovascular health across the world, and highlights what pharmacists can do in order to help support the 2020 goals...
Mark Munger, PharmD, professor, Pharmacotherapy and Internal Medicine, University of Utah, discusses the declining rate of cardiovascular health across the world, and highlights what pharmacists can do in order to help support the 2020 goals...
Mark Munger, PharmD, professor,...
02/10/2021
Pharmacy Learning Network
From Pharmacy Learning Network
Commentary
Update on Hypertension Epidemiology and Treatment for 2021
02/01/2021
Mark Munger, PharmD, discusses recent hypertension research and explains why treatment is important for intensive blood pressure control.
Mark Munger, PharmD, discusses recent hypertension research and explains why treatment is important for intensive blood pressure control.
Mark Munger, PharmD, discusses...
02/01/2021
Pharmacy Learning Network
From Pharmacy Learning Network
News
Cost-Effectiveness of Implantable Loop Recorder Monitoring After Stroke in Line Wth Other Therapies
12/06/2020
For detecting occult atrial fibrillation in patients with cryptogenic stroke, 3-year implantable loop recorder monitoring has a cost per quality-adjusted life-year gained in the range of other publicly funded therapies
For detecting occult atrial fibrillation in patients with cryptogenic stroke, 3-year implantable loop recorder monitoring has a cost per quality-adjusted life-year gained in the range of other publicly funded therapies
For detecting occult atrial...
12/06/2020
First Report Managed Care
From First Report Managed Care

Newsfeed

News
Multidisciplinary Intervention Has No Significant Effect on Heart Failure Readmissions
05/21/2021
A multidisciplinary educational approach to reduce 30-day heart failure readmissions failed to have a significant impact—although readmission rates for patients in both the intervention group and the control group were below national norms.
A multidisciplinary educational approach to reduce 30-day heart failure readmissions failed to have a significant impact—although readmission rates for patients in both the intervention group and the control group were below national norms.
A multidisciplinary educational...
05/21/2021
Pharmacy Learning Network
News
Cost-Effectiveness of Implantable Loop Recorder Monitoring After Stroke in Line Wth Other Therapies
12/06/2020
For detecting occult atrial fibrillation in patients with cryptogenic stroke, 3-year implantable loop recorder monitoring has a cost per quality-adjusted life-year gained in the range of other publicly funded therapies
For detecting occult atrial fibrillation in patients with cryptogenic stroke, 3-year implantable loop recorder monitoring has a cost per quality-adjusted life-year gained in the range of other publicly funded therapies
For detecting occult atrial...
12/06/2020
First Report Managed Care
News
Statin Discontinuation Low Among Older Veterans Near End of Life
08/31/2020
A JAGS study recently examined resident and facility factors that could potentially predict statin discontinuation after nursing home admission in veterans with limited life expectancy or advanced dementia taking statins for secondary...
A JAGS study recently examined resident and facility factors that could potentially predict statin discontinuation after nursing home admission in veterans with limited life expectancy or advanced dementia taking statins for secondary...
A JAGS study recently examined...
08/31/2020
Annals of Long-Term Care
News
Low HDL, Hyperglycemia, Hypertension Linked With Increased Mortality in Older Women
07/02/2020
“The impact of metabolic syndrome components on mortality in older people present some gender differences,” researchers concluded, “with low HDL cholesterol, hyperglycemia, and elevated blood pressure being more strongly associated to...
“The impact of metabolic syndrome components on mortality in older people present some gender differences,” researchers concluded, “with low HDL cholesterol, hyperglycemia, and elevated blood pressure being more strongly associated to...
“The impact of metabolic...
07/02/2020
Annals of Long-Term Care
News
Hypertension Drug Recalled
05/01/2020
A prescription ACE inhibitor used to treat high blood pressure and heart failure is being recalled.
A prescription ACE inhibitor used to treat high blood pressure and heart failure is being recalled.
A prescription ACE inhibitor...
05/01/2020
Pharmacy Learning Network
News
OTC Heartburn Medication Recalled
12/13/2019
Sanofi-Aventis US issued a precautionary, voluntarily recall of all over-the-counter Zantac (ranitidine) products because of possible contamination with NDMA.
Sanofi-Aventis US issued a precautionary, voluntarily recall of all over-the-counter Zantac (ranitidine) products because of possible contamination with NDMA.
Sanofi-Aventis US issued a...
12/13/2019
Pharmacy Learning Network
News
Statins Are Underprescribed, Prescribed at Lower Intensities in Patients With HIV
10/28/2019
Amanda Balbi
“This study reveals that [people living with HIV] may be at a substantial disadvantage in terms of receiving correct statin therapy for ASCVD risk reduction,” the researchers concluded.
“This study reveals that [people living with HIV] may be at a substantial disadvantage in terms of receiving correct statin therapy for ASCVD risk reduction,” the researchers concluded.
“This study reveals that [people...
10/28/2019
Pharmacy Learning Network
News
Walmart Becomes Latest U.S. Retailer to Pull Heartburn Drug Zantac
10/02/2019
Walmart became one of the last remaining major US retailers to suspend the sale of over-the-counter heartburn medication containing ranitidine.
Walmart became one of the last remaining major US retailers to suspend the sale of over-the-counter heartburn medication containing ranitidine.
Walmart became one of the last...
10/02/2019
Pharmacy Learning Network
News
CVS Suspends Sales of Zantac Brand and Generic Heartburn Drug During Safety Review
09/30/2019
According to CVS, the company will discontinue sales of the popular Zantac heartburn treatment and its own generic ranitidine products from its pharmacies after traces of a known carcinogen were found in some of the products.
According to CVS, the company will discontinue sales of the popular Zantac heartburn treatment and its own generic ranitidine products from its pharmacies after traces of a known carcinogen were found in some of the products.
According to CVS, the company...
09/30/2019
Pharmacy Learning Network
News
AI Decision Support System Prevents Unneeded Tests in Patients With Stable Chest Pain
05/24/2019
A clinical decision support tool powered by artificial intelligence can prevent unnecessary diagnostic tests in patients with stable chest pain, according to new research.
A clinical decision support tool powered by artificial intelligence can prevent unnecessary diagnostic tests in patients with stable chest pain, according to new research.
A clinical decision support tool...
05/24/2019
First Report Managed Care
News
Increased Scrutiny of Prior Authorization: Are Payers Fully to Blame, and Can AI Improve the Process?
04/05/2024
Dean Celia
The increased scrutiny of prior authorization, highlighted by media reports and government actions, prompts debate over payer responsibility while exploring the potential for AI to enhance the process.
The increased scrutiny of prior authorization, highlighted by media reports and government actions, prompts debate over payer responsibility while exploring the potential for AI to enhance the process.
The increased scrutiny of prior...
04/05/2024
First Report Managed Care
News
PhRMA Maps Provide State-by-State Look at 340B Drug Program
04/05/2024
Paul Nicolaus
An interactive map made available by the Pharmaceutical Research and Manufacturers of America (PhRMA), a drugmaker advocacy group, shares state-specific data on the 340B Drug Pricing Program. The federal program, initially created over 30...
An interactive map made available by the Pharmaceutical Research and Manufacturers of America (PhRMA), a drugmaker advocacy group, shares state-specific data on the 340B Drug Pricing Program. The federal program, initially created over 30...
An interactive map made...
04/05/2024
First Report Managed Care
News
FTC and HHS Launch Joint Inquiry into Generic Drug Shortages: Seeking Public Input on GPOs and Wholesalers
02/16/2024
Danielle Sposato
In a news release published on February 14, 2024, the US Department of Health and Human Services (HHS) issued a "Request for Information" in collaboration with the Federal Trade Commission (FTC). This request aims to gain insight into how...
In a news release published on February 14, 2024, the US Department of Health and Human Services (HHS) issued a "Request for Information" in collaboration with the Federal Trade Commission (FTC). This request aims to gain insight into how...
In a news release published on...
02/16/2024
First Report Managed Care
News
Medicare Drug Price Negotiations and Anticipated Ripple Effects
02/15/2024
Paul Nicolaus
The arrival of the Inflation Reduction Act has ushered in a new era of drug price regulation, giving the Centers for Medicare & Medicaid Services (CMS) the ability to negotiate directly with companies that make some of the costliest drugs...
The arrival of the Inflation Reduction Act has ushered in a new era of drug price regulation, giving the Centers for Medicare & Medicaid Services (CMS) the ability to negotiate directly with companies that make some of the costliest drugs...
The arrival of the Inflation...
02/15/2024
First Report Managed Care
News
Injectable PrEP Overall Acceptable, Preferred for HIV Prevention
07/15/2023
Maria Asimopoulos
“Given overall acceptability, injectable PrEP should be included as part of a menu of prevention options, allowing end-users to select the modality that suits their preferences, needs and lifestyle,” researchers advised.
“Given overall acceptability, injectable PrEP should be included as part of a menu of prevention options, allowing end-users to select the modality that suits their preferences, needs and lifestyle,” researchers advised.
“Given overall acceptability,...
07/15/2023
First Report Managed Care
News
Low Rate of Social Determinants of Health Z Codes in Adults With Hypertension
06/26/2023
Jolynn Tumolo
Researchers examined the presence and use of ICD-10-CM social determinants of health (SDOH)-related Z codes among adults with hypertension and found differences in documentation and medical expenditures.
Researchers examined the presence and use of ICD-10-CM social determinants of health (SDOH)-related Z codes among adults with hypertension and found differences in documentation and medical expenditures.
Researchers examined the...
06/26/2023
First Report Managed Care
News
CDC Data Shows Link Between High Costs and Prescription Nonadherence in Adults
06/21/2023
Julie Gould
In 2021, medication nonadherence among adults was associated with costs, gender, disability status, insurance coverage, and other characteristics.
In 2021, medication nonadherence among adults was associated with costs, gender, disability status, insurance coverage, and other characteristics.
In 2021, medication nonadherence...
06/21/2023
First Report Managed Care
News
Blood Pressure Injections Recalled
05/26/2023
Jolynn Tumolo
Several thousand products containing phenylephrine and norepinephrine were recalled due to a lack of sterility assurance.
Several thousand products containing phenylephrine and norepinephrine were recalled due to a lack of sterility assurance.
Several thousand products...
05/26/2023
Pharmacy Learning Network
News
Astral SteriTech Recalls 5 Injections Manufactured for 4 US Clients
05/26/2023
Jolynn Tumolo
The recalls, designated Class II by the US Food and Drug Administration, impact a variety of antibiotic injections.
The recalls, designated Class II by the US Food and Drug Administration, impact a variety of antibiotic injections.
The recalls, designated Class II...
05/26/2023
Pharmacy Learning Network
News
Two Firms Recall Statins
04/14/2023
Jolynn Tumolo
Class II recalls have been issued for multiple statins manufactured by two firms and distributed throughout the United States.
Class II recalls have been issued for multiple statins manufactured by two firms and distributed throughout the United States.
Class II recalls have been...
04/14/2023
Pharmacy Learning Network

Insights

Headshot and logo for Talking Therapeutics with Douglas Jennings, PharmD
Talking Therapeutics
Cutting Through Cost Barriers for Heart Failure Medications
03/02/2023
Douglas L. Jennings, PharmD, FACC, FAHA, FCCP, FHFSA, BCPS
In the latest installment of Talking Therapeutics, Dr Jennings provides a brief history of heart failure medications and discusses the cost effectiveness of quadruple, triple, and double therapy regimens.
In the latest installment of Talking Therapeutics, Dr Jennings provides a brief history of heart failure medications and discusses the cost effectiveness of quadruple, triple, and double therapy regimens.
In the latest installment of...
03/02/2023
Pharmacy Learning Network
Headshot and logo for Talking Therapeutics with Douglas Jennings, PharmD
Talking Therapeutics
ACC Updates Part 2
06/01/2021
Douglas L. Jennings, PharmD, FACC, FAHA, FCCP, FHFSA, BCPS
Last week’s edition of Talking Therapeutics highlighted several new and exciting studies related to heart failure drug therapies. This week we tackle three more pivotal trials from this year’s exciting conference.
Last week’s edition of Talking Therapeutics highlighted several new and exciting studies related to heart failure drug therapies. This week we tackle three more pivotal trials from this year’s exciting conference.
Last week’s edition of Talking...
06/01/2021
Pharmacy Learning Network
Headshot of Mark Munger, PharmD
Commentary
An Update on Heart Failure: World-Wide Burden, Rural Versus Urban Adults, Ethnic Disparities, and Remote Monitoring
06/01/2021
Mark A. Munger, PharmD, FCCP, FACC, FHFSA
Mark Munger, PharmD, provides up-to-date information on heart failure across the world, related mortality in rural versus urban adults, ethnic disparities in US outcomes, and potential innovations of heart failure care.
Mark Munger, PharmD, provides up-to-date information on heart failure across the world, related mortality in rural versus urban adults, ethnic disparities in US outcomes, and potential innovations of heart failure care.
Mark Munger, PharmD, provides...
06/01/2021
Pharmacy Learning Network
Talking Therapeutics
Heart Failure Treatment Insight From ACC.2021
05/19/2021
Douglas L. Jennings, PharmD, FACC, FAHA, FCCP, FHFSA, BCPS
In this week's installment of Talking Therapeutics, Dr Jennings offers a breakdown on the latest heart failure therapy data, which was recently presented at the American College of Cardiology's annual meeting.
In this week's installment of Talking Therapeutics, Dr Jennings offers a breakdown on the latest heart failure therapy data, which was recently presented at the American College of Cardiology's annual meeting.
In this week's installment of...
05/19/2021
Pharmacy Learning Network
Commentary
Hypertension, Hyperlipidemia for Developing and Sustaining Atrial Fibrillation
05/04/2021
“Goal-directed use of antihypertensives and statin drugs appear to be effective strategies to reduce atrial fibrillation incidence, morbidity, and mortality,” says Mark Munger, PharmD.
“Goal-directed use of antihypertensives and statin drugs appear to be effective strategies to reduce atrial fibrillation incidence, morbidity, and mortality,” says Mark Munger, PharmD.
“Goal-directed use of...
05/04/2021
Pharmacy Learning Network
Talking Therapeutics
V is for Victory in Heart Failure
04/28/2021
In this week’s issue of Talking Therapeutics, Dr Jennings explores the science and promise of a recently approved novel medication for patients with HFrEF.
In this week’s issue of Talking Therapeutics, Dr Jennings explores the science and promise of a recently approved novel medication for patients with HFrEF.
In this week’s issue of Talking...
04/28/2021
Pharmacy Learning Network
Talking Therapeutics
Targeting Inflammation to Treat Coronary Artery Disease
04/20/2021
Dr Jennings reviews evidence supporting colchicine use to further reduce residual disease burden in coronary artery disease but highlights why pharmacists need to keep several things in mind when dispensing colchicine to ensure that patients...
Dr Jennings reviews evidence supporting colchicine use to further reduce residual disease burden in coronary artery disease but highlights why pharmacists need to keep several things in mind when dispensing colchicine to ensure that patients...
Dr Jennings reviews evidence...
04/20/2021
Pharmacy Learning Network
Commentary
Using Medication Fill Records to Help Predict Nonadherence of Statins in New Users
10/29/2020
Zahra Majd, PharmD, Department of Pharmaceutical Health Outcomes and Policy, College of Pharmacy, University of Houston, discusses the results of a recent study that highlights the value of using records of past medication fills and adherence...
Zahra Majd, PharmD, Department of Pharmaceutical Health Outcomes and Policy, College of Pharmacy, University of Houston, discusses the results of a recent study that highlights the value of using records of past medication fills and adherence...
Zahra Majd, PharmD, Department...
10/29/2020
Pharmacy Learning Network
Interview
Limiting Major CVD Events With Metformin in Vets With Diabetes, Reduced Kidney Function
03/02/2020
Christianne Roumie, MD, MPH, associate professor of Internal Medicine and Pediatrics at Vanderbilt University Medical Center and the VA Tennessee Valley Healthcare System, discusses the benefits of the diabetes medication metformin on...
Christianne Roumie, MD, MPH, associate professor of Internal Medicine and Pediatrics at Vanderbilt University Medical Center and the VA Tennessee Valley Healthcare System, discusses the benefits of the diabetes medication metformin on...
Christianne Roumie, MD, MPH,...
03/02/2020
Veterans Health Today

Interactive Features

HMP Global Products

Events

HMP Education Logo
HMP Omnimedia Logo
HMP Europe Logo
© 2026 HMP Global. All Rights Reserved.
Cookie Policy Privacy Policy Terms of Use